No Data
Ho\'s Ophthalmology: 2024 Semi-Annual Report Summary
Ho\'s Ophthalmology: Semi-Annual Report 2024
Huan Shi Ophthalmology (301103.SZ) released its performance for the first half of the year, with a net income of 24.064 million yuan, a decrease of 69.29% year-on-year.
He Shi Eye Hospital (301103.SZ) released its 2024 interim report, reporting a revenue of 5... for the reporting period...
CEO Wei He, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Largest Shareholder Sees Value of Holdings Go Down 12% After Recent Drop
Ho's Ophthalmology (301103.SZ) plans to distribute 10 shares of 6.050416 yuan to be deducted from interest on July 5
Heshi Ophthalmology (301103.SZ) announcement, the company's annual equity distribution in 2023 will be distributed to all shareholders at a rate of 10 shares per...
Heshi Ophthalmology (301103.SZ): Cumulative expenditure of 67.5 million yuan to repurchase 1.72% of the shares.
On June 20th, Gelonhui reported that as of June 19th, 2024, the company has repurchased a total of 2,722,719 shares through a share repurchase special securities account using centralized bidding trading, accounting for 1.72% of the company's total share capital. The highest fill price was 31.36 yuan/share, the lowest fill price was 19.98 yuan/share, and the total trade amount was 67,503,537.37 yuan (excluding transaction fees). As of the disclosure date of this announcement, the company's share repurchase plan has been completed.
Liaoning He Eye Hospital Group (SZSE:301103) Could Be Struggling To Allocate CapitalNo Data
